Literature DB >> 31201428

Variation in colorectal cancer testing between primary care physicians: a cross-sectional study in Switzerland.

Alexander Leonhard Braun1, Emanuele Prati1, Yonas Martin1, Charles Dvořák2, Kali Tal1, Nikola Biller-Andorno3, Jean-Luc Bulliard4, Jacques Cornuz4, Kevin Selby4,5, Reto Auer6,7.   

Abstract

OBJECTIVES: To determine the proportion of 50-75-year-old patients who visit a primary care physician's (PCP) office and were tested for colorectal cancer (CRC) by either colonoscopy within 10 years or fecal occult blood testing (FOBT) within 2 years. To describe the variation in care between PCPs and factors associated with these proportions.
METHODS: Cross-sectional data collected between April and December 2017. PARTICIPANTS: PCPs reporting for the Swiss Sentinel Surveillance Network. Each PCP collected demographic data and CRC testing status from 40 consecutive patients. MEASUREMENTS: proportions of patients up to date with CRC screening and method used (colonoscopy/FOBT/Other); variation in the outcome measures between PCPs; association of physician-level factors with main outcomes.
RESULTS: 91/129 PCPs collected data from 3451 patients; 45% had been tested for CRC within recommended intervals (41% colonoscopy, 4% FOBT). The proportions of patients tested and testing with colonoscopy versus FOBT varied widely between PCPs. Language region was associated with PCPs' rate of FOBT prescription.
CONCLUSIONS: Less than half of patients who visited PCPs in Switzerland were tested for CRC within recommended intervals. PCPs varied widely in their testing practices.

Entities:  

Keywords:  Colorectal cancer; Decision making; Practice variation; Primary care; Screening

Mesh:

Year:  2019        PMID: 31201428     DOI: 10.1007/s00038-019-01259-4

Source DB:  PubMed          Journal:  Int J Public Health        ISSN: 1661-8556            Impact factor:   3.380


  25 in total

1.  Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).

Authors:  C Stock; H Brenner
Journal:  Endoscopy       Date:  2010-04-29       Impact factor: 10.093

2.  Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.

Authors:  C Stock; P Ihle; I Schubert; H Brenner
Journal:  Endoscopy       Date:  2011-08-09       Impact factor: 10.093

3.  Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening.

Authors:  Dolores Salas; Mercedes Vanaclocha; Josefa Ibáñez; Ana Molina-Barceló; Vicente Hernández; Joaquín Cubiella; Raquel Zubizarreta; Montserrat Andreu; Cristina Hernández; Francisco Pérez-Riquelme; José Cruzado; Fernando Carballo; Luis Bujanda; Cristina Sarasqueta; Isabel Portillo; Mariola de la Vega-Prieto; Juan Diego Morillas; Vicente Valentín; Angel Lanas; Enrique Quintero; Antoni Castells
Journal:  Cancer Causes Control       Date:  2014-05-24       Impact factor: 2.506

4.  American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008.

Authors:  Oralia Garcia Dominic; Thomas McGarrity; Mark Dignan; Eugene J Lengerich
Journal:  Am J Gastroenterol       Date:  2009-10       Impact factor: 10.864

5.  European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.

Authors:  L von Karsa; J Patnick; N Segnan; W Atkin; S Halloran; I Lansdorp-Vogelaar; N Malila; S Minozzi; S Moss; P Quirke; R J Steele; M Vieth; L Aabakken; L Altenhofen; R Ancelle-Park; N Antoljak; A Anttila; P Armaroli; S Arrossi; J Austoker; R Banzi; C Bellisario; J Blom; H Brenner; M Bretthauer; M Camargo Cancela; G Costamagna; J Cuzick; M Dai; J Daniel; E Dekker; N Delicata; S Ducarroz; H Erfkamp; J A Espinàs; J Faivre; L Faulds Wood; A Flugelman; S Frkovic-Grazio; B Geller; L Giordano; G Grazzini; J Green; C Hamashima; C Herrmann; P Hewitson; G Hoff; I Holten; R Jover; M F Kaminski; E J Kuipers; J Kurtinaitis; R Lambert; G Launoy; W Lee; R Leicester; M Leja; D Lieberman; T Lignini; E Lucas; E Lynge; S Mádai; J Marinho; J Maučec Zakotnik; G Minoli; C Monk; A Morais; R Muwonge; M Nadel; L Neamtiu; M Peris Tuser; M Pignone; C Pox; M Primic-Zakelj; J Psaila; L Rabeneck; D Ransohoff; M Rasmussen; J Regula; J Ren; G Rennert; J Rey; R H Riddell; M Risio; V Rodrigues; H Saito; C Sauvaget; A Scharpantgen; W Schmiegel; C Senore; M Siddiqi; D Sighoko; R Smith; S Smith; S Suchanek; E Suonio; W Tong; S Törnberg; E Van Cutsem; L Vignatelli; P Villain; L Voti; H Watanabe; J Watson; S Winawer; G Young; V Zaksas; M Zappa; R Valori
Journal:  Endoscopy       Date:  2012-12-04       Impact factor: 10.093

Review 6.  Agreement between self-reported and registered colorectal cancer screening: a meta-analysis.

Authors:  D Dodou; J C F de Winter
Journal:  Eur J Cancer Care (Engl)       Date:  2014-04-23       Impact factor: 2.520

7.  Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.

Authors:  John M Inadomi; Sandeep Vijan; Nancy K Janz; Angela Fagerlin; Jennifer P Thomas; Yunghui V Lin; Roxana Muñoz; Chim Lau; Ma Somsouk; Najwa El-Nachef; Rodney A Hayward
Journal:  Arch Intern Med       Date:  2012-04-09

8.  Predictors of colorectal cancer screening variation among primary-care providers and clinics.

Authors:  Jennifer M Weiss; Maureen A Smith; Perry J Pickhardt; Sally A Kraft; Grace E Flood; David H Kim; Elizabeth Strutz; Patrick R Pfau
Journal:  Am J Gastroenterol       Date:  2013-05-14       Impact factor: 10.864

9.  Obesity and overweight associated with lower rates of colorectal cancer screening in Switzerland.

Authors:  Roland Fischer; Tinh-Hai Collet; Andreas Zeller; Lukas Zimmerli; Jean-Michel Gaspoz; Karine Giraudon; Nicolas Rodondi; Jacques Cornuz
Journal:  Eur J Cancer Prev       Date:  2013-09       Impact factor: 2.497

Review 10.  Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies.

Authors:  Hermann Brenner; Christian Stock; Michael Hoffmeister
Journal:  BMJ       Date:  2014-04-09
View more
  5 in total

1.  Ten-year changes in colorectal cancer screening in Switzerland: The Swiss Health Interview Survey 2007, 2012 and 2017.

Authors:  Rémi Schneider; Lamprini Syrogiannouli; Sarah Bissig; Tamara Scharf; Jean-Luc Bulliard; Cyril Ducros; Cinzia Del Giovane; Kali Tal; Marcel Zwahlen; Kevin Selby; Reto Auer
Journal:  Prev Med Rep       Date:  2022-05-06

2.  Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study.

Authors:  Caroline Bähler; Beat Brüngger; Agne Ulyte; Matthias Schwenkglenks; Viktor von Wyl; Holger Dressel; Oliver Gruebner; Wenjia Wei; Eva Blozik
Journal:  BMC Public Health       Date:  2021-01-05       Impact factor: 3.295

3.  Colorectal Cancer Screening Prevalence and Adherence for the Cancer Prevention Project of Philadelphia (CAP3) Participants Who Self-Identify as Black.

Authors:  Elizabeth L Blackman; Camille Ragin; Resa M Jones
Journal:  Front Oncol       Date:  2021-07-30       Impact factor: 6.244

4.  Offering patients a choice for colorectal cancer screening: a quality improvement pilot study in a quality circle of primary care physicians.

Authors:  Yonas Martin; Leo Alexander Braun; Marc-Andrea Janggen; Kali Tal; Nikola Biller-Andorno; Cyril Ducros; Kevin Selby; Reto Auer; Adrian Rohrbasser
Journal:  BMJ Open Qual       Date:  2019-10-03

5.  Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.

Authors:  Agne Ulyte; Wenjia Wei; Holger Dressel; Oliver Gruebner; Viktor von Wyl; Caroline Bähler; Eva Blozik; Beat Brüngger; Matthias Schwenkglenks
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.